FTC wades into escalating ‘Orange Book’ clash
Jazz accused a rival of infringement | Avadel filed a counterclaim seeking to delist the patent from the Orange Book.
English appeals court rejects jurisdiction challenge over cannabis sativa collab
Case concerns epilepsy drug patent and medical cannabis R&D collaboration | Dispute between Japanese and Irish pharma firms will be heard in London due to arbitration carve-out clause.
SCOTUS rejects BMS vs Gilead patent clash
Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices.
Spruson & Ferguson adds litigator to life sciences team
Spruson & Ferguson has hired litigator Katrina Crooks as a principal, who will join its office in Sydney.
NGOs attack UK’s ‘disastrous’ IP proposals to India
Humanitarian organisations censure leaked IP provisions within UK-India free trade agreement | “Excessive measures” would “drastically harm access” to affordable, lifesaving generic medicines from India.
SCOTUS agrees to hear Amgen revival bid
The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.
Analysis: Ventria on ITC win barring rHSA products
Counsel for Ventria sat down with Sarah Speight to explore their landmark win at the International Trade Commission, which led to a US ban for a Chinese company
Patent firm’s Sweden office expands with partner hire
Patent law firm EIP has hired Pontus Falk as a partner at its recently opened Sweden office.
Big pharma co buys $16.6bn for heart tech company
Cardiovascular ‘innovator’ snapped up as company strengthens medtech offering | Massachusetts-based Abiomed will become part of purchaser’s medtech division
Pharma firm voluntarily licences cancer drug in novel deal
Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for generic manufacturers
